Featured Article

Noctura 400 has racked up 2 million hours of patient use and has maintained CE for 10 years

Noctura 400 first received a CE mark under the EU Medical Device Directive in 2014, for the treatment and prevention of diabetic retinopathy. To gain ...

Diabetic Retinopathy Patients Home Treatment Results

We can support our patients with diabetic retinopathy throughout their treatment with Noctura 4...

Desang Diabetes Magazine Talks About Noctura 400!

If you’re enjoying relaxing over the festive period and want an informative read about Noctura 400, ...

Noctura 400 featured in the Telegraph!

Telegraph featuring us over Christmas – and to let everyone know that Noctura 400 is now available f...

Noctura 400 is supplied to patients by ASPH NHS Trust!

We’re really happy that Noctura 400 is now available from one NHS Trust, and it’s great to be featur...

Noctura 400 at Diabetes Professional Care event, London

PolyPhotonix were at Stand E02, Diabetes Professional Care event, London last week, showing off the ...

The Daily Mail reports great potential savings

Noctura 400 is featured in a Daily Mail report explaining the cost saving it could bring if adopted ...

Dr. Meyer-Bothling explains Diabetic Retinopathy treatment options – including Noctura 400

During Diabetes Week 2022 on TopDoctorsUK, the Chief Investigator of a recent successful Noctura 400...

Noctura 400 featured on BBC Radio Tees

CEO Richard Kirk talks about the development and successes of Noctura 400. With an in depth understa...

Pancreas 404 – a patients reflection on diabetes and Noctura 400.

An Italian Noctura 400 patient talks about his diabetic life experience, the very real possibility o...